Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH.
Evseev D, Osipova D, Kalinina I, Raykina E, Ignatova A, Lyudovskikh E, Baidildina D, Popov A, Zhogov V, Semchenkova A, Litvin E, Kotskaya N, Cherniak E, Voronin K, Burtsev E, Bronin G, Vlasova I, Purbueva B, Fink O, Pristanskova E, Dzhukaeva I, Erega E, Novichkova G, Maschan A, Maschan M. Evseev D, et al. Among authors: osipova d. Blood Adv. 2023 Sep 26;7(18):5246-5257. doi: 10.1182/bloodadvances.2022009067. Blood Adv. 2023. PMID: 37216396 Free PMC article.
Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA.
Evseev D, Kalinina I, Raykina E, Osipova D, Abashidze Z, Ignatova A, Mitrofanova A, Maschan A, Novichkova G, Maschan M. Evseev D, et al. Among authors: osipova d. Int J Hematol. 2021 Dec;114(6):725-734. doi: 10.1007/s12185-021-03205-8. Epub 2021 Aug 12. Int J Hematol. 2021. PMID: 34383272
Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study.
Ukrainskaya V, Molostova O, Shelikhova L, Pershin D, Kulakovskaya E, Volkov D, Rakhteenko A, Muzalevskii Y, Kazachenok A, Brilliantova V, Osipova D, Rubtsov Y, Stepanov A, Maschan M. Ukrainskaya V, et al. Among authors: osipova d. Blood Adv. 2022 Oct 11;6(19):5582-5588. doi: 10.1182/bloodadvances.2021006262. Blood Adv. 2022. PMID: 35446932 Free PMC article. No abstract available.
Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning.
Stepanova VM, Volkov DV, Osipova DS, Wang W, Hou Y, Pershin DE, Fadeeva MS, Malakhova EA, Kulakovskaya EA, Cuicui L, Mingfeng Z, Zhang H, Xie J, Zhang D, Mamedov IZ, Chernov AS, Telegin GB, Rubtsov YP, Gabibov AG, Wu P, Maschan MA, Stepanov AV. Stepanova VM, et al. Among authors: osipova ds. Mol Ther Oncol. 2024 Jun 27;32(3):200843. doi: 10.1016/j.omton.2024.200843. eCollection 2024 Sep 19. Mol Ther Oncol. 2024. PMID: 39822756 Free PMC article.
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Spiera RF, et al. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. N Engl J Med. 2023. PMID: 37792612 Clinical Trial.
41 results